Drug industry’s growth trends examined, alongside typical distribution methods.

Feedback states Health Canada’s chosen regulatory model increases risk to drug plans.

Third annual report finds only one in five say their financial situation is strong.

Work interruption episodes to be addressed with the option of genetic testing.

Financial pressure is forcing one in five Canadians to skimp on health spending.

Canadians under 35 suffering from mental disorders feature prominently in claims data.

Cardiovascular disease and cancer top the list of conditions driving plan costs.